Maks Pharma And Diagnostics Inc is categorized under Drug Brokers in Farmingdale, NY and active since 2012.
Maks Pharma And Diagnostics Inc was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Sadathulla Shareef at the company’s single location by writing to 46 Central Drive, Farmingdale, New York NY 11735 or by phoning (631) 270-1528. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Maks Pharma And Diagnostics Inc |
| Contact Person: | Sadathulla Shareef |
| Address: | 46 Central Drive, Farmingdale, New York 11735 |
| Phone Number: | (631) 270-1528 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Drug Brokers |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Maks Pharma And Diagnostics Inc was started in 2012 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sadathulla Shareef for inquiries that concern Maks Pharma And Diagnostics Inc by calling the company number (631) 270-1528, as your correspondence is most welcome. Additionally, the physical location of the single location of Maks Pharma And Diagnostics Inc can be found at the coordinates 40.754981,-73.409442 as well as the street address 46 Central Drive in Farmingdale, New York 11735.
For its online presence, you may visit Maks Pharma And Diagnostics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.